HPV Vaccination and Perceptions Among College Males

In the US, individuals between ages 18-26 years old have the highest incidence of new HPV infection, the most common sexually transmitted infection. HPV infection can lead to the development of non-cancerous genital warts and persistent infection with cancerous strains can cause various cancers. An HPV vaccine which offers protection against seven cancerous strains and the two non-cancerous strains which cause genital warts has recommended for use by the Centers for Disease Control and Prevention for both men and women beginning in 2011. However, young adult men, including college-aged men, are lagging in HPV vaccine uptake and completion. This cross-sectional study, guided by the Health Belief Model and Theory of Planned Behavior, seeks to explore college men’s behaviors and intentions to getting the HPV vaccine (primary outcomes). It also seeks to explore their perceived susceptibility and severity of HPV infection; attitudes about the HPV vaccine, self-efficacy and social norms to vaccinate, and stigma related to HPV infection (secondary outcomes). Study results showed that only 33% of college men reported knowing they had received at least one dose of the HPV vaccine. The majority of men reported they had never had a conversation about the HPV vaccine with their primary care provider. Overall, men had positive attitudes about the HPV vaccine, high self-efficacy to communicate and access the vaccine, but low intentions and low social norms to vaccinate against this virus. Outcomes of this research suggest the need for future intervention work to focus on increasing college males’ social norms to vaccinate against HPV. Influencing parents, peers, and other influential individuals to encourage college males to vaccinate against HPV may, in fact, increase their intentions and behaviors to utilize this cancer prevention resource.